SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON)
MSON 26.540.0%Nov 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Candle stick who wrote (487)10/30/1997 9:42:00 AM
From: Candle stick  Read Replies (1) of 947
 
This appears to be an excellent earnings report: The following are the most significant points, IMHO:

1)Revenues increased 80% and pretax income increased 196%

2) Earnings .13 is excellent given there were 53% more shares in the float

3)"particularly noteworthy during the quarter was United States Surgical Corporation's (NYSE: USS) earlier-than-expected initial production order for our ultrasonic surgical technology".......this means earlier than expected earnings, coming from the quarter we are currently in.

4)"continued strong performance of our core scientific and industrial products divisions, which registered a 21% increase in revenues in the first quarter"............ALL business is doing well

5) "Mystaire division received its single largest order ever for an air pollution system,"........this was also unexpected and will add to earnings in the current quarter........

.........all in all I would say there is alot to look forward to in the coming quarter and MSON has shown that they are NOT a one trick pony, and can produce on all fronts......best of luck to all.....I remain of the opinion that MSON is grossly undervalued and should be agressively bought for the long term.........;^)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext